Investigating NMJ Defects in SMA Following Central and Peripheral SMN Restoration

计划入组 18 人 · 首次发布于 2022 年 2 月 2 日

RCT of Combination Effect of Vibration Treatment and HMB Supplementation on Myosteatosis and NMJ Degeneration

计划入组 200 人 · 首次发布于 2022 年 9 月 1 日

Field Trial of a Relapse Prevention Program for Adolescents Receiving Substance Use Treatment

计划入组 160 人 · 首次发布于 2014 年 4 月 29 日

NMJ-2

NMJ-3

NRT-NMJ_002

NMT Medical

Canada

MMJ LABS, LLC

United States

RMJ HOLDINGS, LLC

United States

Darifenacin Repurposing for ALS Treatment Supported by Neuromuscular Junction Research

Andelyn Biosciences Partners with Amplo Biotechnology to Advance AAV Gene Therapies for Neuromuscular Junction Disorders

NMD Pharma's NMD670 Enters Phase 2 Trial for Charcot-Marie-Tooth Disease